LITMUS Imaging Study

Inclusion Criteria:

1. Recruited to the European NAFLD Registry

2. Patient had a liver biopsy less than 3 months prior to enrolment into the study oris having a liver biopsy in less than 3 months' time for the assessment of NAFLD.

3. Participant is willing and able to give informed consent for participation in thestudy.

Exclusion Criteria:

1. Patients that do not speak the language in which the patient information is writtenwill be excluded. Due to the nature of the study, being able to read the informationabout the study or access to a relevant interpreter is a necessary criterion forparticipant's safety in regards to MR scanning.

2. Patients judged by the investigator to be unsuitable for inclusion in the study (e.g. where the investigator feels that the participant will not be able to complywith the study procedures)

3. Any contra-indication to Magnetic Resonance Imaging (MRI) (e.g. ferrous metalimplants/fragments, implantable cardiac defibrillator or permanent pacemaker, metalclips following neurosurgery, pregnancy, other condition that would make MR scanningunsafe in the opinion of the scanner operator)